BioSpace News Archive

According to the global Cancer Gene Therapy market size is expected to surpass around USD 5.9 billion by 2030 from valued at USD 2.4 billion in 2022 and growing at a CAGR of 10.7% from 2022 to 2030.

According to the report, the global cytology and HPV testing market was valued at US$ 7.42 Bn in 2021 and is anticipated to expand at a CAGR of 5.9% from 2022 to 2030

Trethera Corporation (“Trethera”), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) to TRE-515, Trethera’s first-in-class drug for the treatment of acute disseminated encephalomyelitis (ADEM).

The latest market analysis report published by Reports and Data, titled ‘Global Germ Cell Tumor Market – Forecast to 2030,’ thoroughly examines the Germ Cell Tumor industry to provide essential data & information for the targeted readers

The global Dry Eye Syndrome Drugs market size is projected to reach US$ 10300 million by 2030, from US$ 6742.4 million in 2021, at a CAGR of 6.1% during 2022-2030.

According to the report, the global oligonucleotide synthesis market was valued at US$ 1,966.2 Mn in 2021 and is anticipated to expand at a CAGR of 9.5% from 2022 to 2030

According to the global Cell Banking Outsourcing market size was estimated at USD 9,869.5 million in 2021 and is expected to surpass around USD 35,593.6 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 16.40% during the forecast period 2022 to 2030.

According to the report, the global bioprocess technology market was valued at US$ 21.9 Bn in 2021 and is anticipated to expand at a CAGR of 7.9% from 2022 to 2030

According to Nova one advisor, the global Cell Culture market size was estimated at USD 21.05 billion in 2021 and is expected to surpass around USD 60.27 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 11.9% during the forecast period 2022 to 2030.

Wilmington, Delaware, United States, Transparency Market Research Inc. – Cutaneous T-cell lymphoma is a rare type of cancer that begins in white blood cells, called T cells (T lymphocytes).